# OnCo record paper-nhs-galleri-design-cancers-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nhs-galleri-design-cancers-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nhs-galleri-design-cancers-2022" ;
  schema:name "NHS-Galleri: design of the largest randomised trial of a multi-cancer blood test"@en ;
  schema:description "The NHS-Galleri design paper is the protocol for a 140,000-person randomised trial in England testing whether three annual Galleri blood tests reduce late-stage (III-IV) cancer diagnoses, the first MCED trial powered for a stage-shift endpoint."@en ;
  schema:url <https://onco.cc/key-papers/paper-nhs-galleri-design-cancers-2022/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.3390/cancers14194818>, <https://www.nhs-galleri.org> ;
  schema:sameAs <https://doi.org/10.3390/cancers14194818> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Neal RD, Johnson P, Clarke CA, et al." ;
  onco:related <https://onco.cc/roadmaps/early-detection-roadmap/>, <https://onco.cc/ideas/idea-prev-mced-stage-endpoint-surrogate/>, <https://onco.cc/ideas/idea-prev-mced-registry-randomised/> ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:drugs <https://onco.cc/drugs/galleri/> ;
  onco:terms <https://onco.cc/terms/stage-shift/>, <https://onco.cc/terms/ppv/> ;
  onco:trials <https://onco.cc/trials/nhs-galleri/>, <https://onco.cc/trials/pathfinder-2/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-overdiagnosis/> ;
  onco:journals <https://onco.cc/journals/cancers-mdpi/> .